1. Yoon HJ, Seok JH. Clinical factors associated with quality of life in patients with thyroid cancer. Journal of Korean Thyroid Association. 2014; 7(1):62–9. https://doi.org/10.11106/jkta.2014.7.1.62.
Article
2. Ministry of Health and Welfare/Korea Central Cancer Registry. A press release on cancer statistics in 2015 [Internet]. Seoul: Ministry of Health and Welfare/Korea Central Cancer Registry;2017. [cited 2017 December 23] Available from:. https://ncc.re.kr/cancerStatsView.ncc?bbsnum=418&searchKey=total&searchValue=&pageNum=1https://ncc.re.kr/cancerStatsView.ncc?bbsnum=418&searchKey=total&searchValue=&pageNum=1.
3. Yi KH, Park YJ, Koong SS, Kim JH, Na DG, Ryu JS, et al. Revis-ed Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer. Endocrinology and Metabolism. 2010; 25(4):270–97. https://doi.org/10.3803/EnM.2010.25.4.270.
Article
4. Yoo SH, Choi-Kwon S. Changes in quality of life and related factors in thyroid cancer patients with radioactive iodine remnant ablation. Journal of Korean Academy of Nursing. 2013; 43(6):801–11. https://doi.org/10.4040/jkan.2013.43.6.801.
Article
5. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Health-related quality of life among thyroid cancer survivors: a systematic review. Clinical Endocrinology. 2011; 75(4):544–54. https://doi.org/10.1111/j.1365-2265.2011.04114.x.
Article
6. Kim JS. Postoperative quality of life in patients with papillary thyroid cancer. Journal of the Korea Academia-Industrial Cooperation Society. 2011; 12(3):1260–9. https://doi.org/10.5762/KAIS.2011.12.3.1260.
Article
7. Lee JI, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, et al. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health and Quality of Life Outcomes. 2010; 8:101. https://doi.org/10.1186/1477-7525-8-101.
Article
8. Taïeb D, Sebag F, Cherenko M, Baumstarck-Barrau K. Forta-nier C, Farman-Ara B, et al. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clinical Endocrinology. 2009; 71(1):115–23. https://doi.org/10.1111/j.1365-2265.2008.03424.x.
9. Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 longterm cancer survivors. International Journal of Cancer. 2003; 104(4):488–95. https://doi.org/10.1002/ijc.10981.
Article
10. Vassilopoulou-Sellin R. Low-risk papillary thyroid cancer: treatment options and patient perceptions. Oncology. 2009; 23(7):589–92.
11. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association. 1995; 273(1):59–65. https://doi.org/10.1001/jama.1995.03520250075037.
Article
12. Wang TS, Cheung K, Mehta P, Roman SA, Walker HD, Sosa JA. To stimulate or withdrawal? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States. The Journal of Clinical Endocrinology & Metabolism. 2010; 95(4):1672–80. https://doi.org/10.1210/jc.2009-1803.
13. Kita T, Yokoyama K, Higuchi T, Kinuya S, Taki J, Nakajima K. Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma. Annals of Nuclear Medicine. 2004; 18(4):345–9. https://doi.org/10.1007/BF02984474.
14. Rubic M, Kuna SK, Tesic V, Samardzic T, Despot M, Huic D. The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal. Psy-chiatria Danubina. 2014; 26(Suppl. 3):520–7.
15. An JY, An K, O'Connor L, Wexler S. Life satisfaction, self-es-teem, and perceived health status among elder Korean women: focus on living arrangements. Journal of Transcultural Nursing. 2008; 19(2):151–60. https://doi.org/10.1177/1043659607313070.
Article
16. Hirsch D, Ginat M, Levy S, Benbassat C, Weinstein R, Tsvetov G, et al. Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid. 2009; 19(5):459–65. https://doi.org/10.1089/thy.2008.0360.
Article
17. Kim HS. The difference in symptom severity, symptom inter-ference, depression, fighting spirit, and social support between younger and older patients with cancer. Journal of the Korean Data Analysis Society. 2014; 16(4):2143–59.
18. Kritpracha C. Influences of cognitive representations of breast cancer on emotional responses and coping in Thai women newly diagnosed with breast cancer [dissertation]. Ann Arbor: The University of Michigan;2004.
19. Almeida JP, Vartanian JG, Kowalski LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Archives of Otolaryngology-Head & Neck Surgery. 2009; 135(4):342–6. https://doi.org/10.1001/archoto.2009.16.
Article
20. Roberts KJ, Lepore SJ, Urken ML. Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. Journal of Cancer Education. 2008; 23(3):186–91. https://doi.org/10.1080/08858190802247762.
Article
21. Efficace F, Baccarani M, Breccia M, Cottone F, Alimena G, Deli-liers GL, et al. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia. 2013; 27(7):1511–9. https://doi.org/10.1038/leu.2013.51.
Article
22. Kim CH. Factors affecting symptom experiences and health- related quality of life in the patients with thyroid cancer [dissertation]. Seoul: Yonsei University;2006.
23. Kim GS. Easy SEM with SmartPLS. Seoul: CheongRam Publishing;2013.
24. Dow KH, Ferrel BR, Anello C. Quality of life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid. 1997; 7(4):613–9. https://doi.org/10.1089/thy.1997.7.613.
25. Sherbourne CD, Stewart AL. The MOS social support survey. Social Science & Medicine. 1991; 32(6):705–14. https://doi.org/10.1016/0277-9536(91)90150-B.
Article
26. Lim MK. Relationships between social support and health among low income groups in urban area [master's thesis]. Seoul: Seoul National University;2002.
27. Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, et al. Development and initial validation of the thyroid cancer module of the M.D. Anderson Symptom Inventory. Oncology. 2009; 76(1):59–68. https://doi.org/10.1159/000178809.
28. Bae BR. Structural equation modeling with Amos 21: principles and practice. Seoul: CheongRam Publishing;2014.
29. Hair JF, Hult GTM, Ringle CM, Sarstedt M. Primer on partial least squares structural equation modeling (PLS-SEM). 1st ed.Kim JH, Shim KH, Lee CS, translator. Goyang: PNC Media;2014.
30. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. Journal of Psychosomatic Research. 2006; 60(6):631–7. https://doi.org/10.1016/j.jpsychores.2005.10.020.
Article
31. Seong YS, Lee YW. Relationship of illness perception, self-efficacy, and self-care among pulmonary tuberculosis patients. Korean Journal of Adult Nursing. 2011; 23(1):31–9.
32. Huang SM, Lee CH, Chien LY, Liu HE, Tai CJ. Postoperative quality of life among patients with thyroid cancer. Journal of Advanced Nursing. 2004; 47(5):492–9. https://doi.org/10.1111/j.1365-2648.2004.03128.x.
Article
33. Han SS, Shin IS, Kim YJ. Factors that influence quality of life in cancer patients. Korean Journal of Health Promotion. 2009; 9(1):33–40.
34. Kim KO, Kim JA. Influences of uncertainty and social support on the quality of life among elderly cancer patients. Asian Oncology Nursing. 2017; 17(3):180–7. https://doi.org/10.5388/aon.2017.17.3.180.
Article
35. Ahn HJ, Tae YS, Han YI. The relationship between spiritual health and uncertainty in cancer patients having chemotherapy. Journal of Korean Oncology Nursing. 2007; 7:107–18.
36. Oh J, Yi M. Structural equation modeling on quality of life in older adults with osteoarthritis. Journal of Korean Academy of Nursing. 2014; 44(1):75–85. https://doi.org/10.4040/jkan.2014.44.1.75.
Article